Abstract:Purpose: This study aims to develop an optimal machine learning model that uses lung equivalent uniform dose (lung EUD to predict radiation pneumonitis (RP) occurrence in lung cancer patients treated with volumetric modulated arc therapy (VMAT). Methods: We analyzed a cohort of 77 patients diagnosed with locally advanced squamous cell lung cancer (LASCLC) receiving concurrent chemoradiotherapy with VMAT. Patients were categorized based on the onset of grade II or higher radiation pneumonitis (RP 2+). Dose volume histogram data, extracted from the treatment planning system, were used to compute the lung EUD values for both groups using a specialized numerical analysis code. We identified the parameter α, representing the most significant relative difference in lung EUD between the two groups. The predictive potential of variables for RP2+, including physical dose metrics, lung EUD, normal tissue complication probability (NTCP) from the Lyman-Kutcher-Burman (LKB) model, and lung EUD-calibrated NTCP for affected and whole lung, underwent both univariate and multivariate analyses. Relevant variables were then employed as inputs for machine learning models: multiple logistic regression (MLR), support vector machine (SVM), decision tree (DT), and K-nearest neighbor (KNN). Each model's performance was gauged using the area under the curve (AUC), determining the best-performing model. Results: The optimal α-value for lung EUD was 0.3, maximizing the relative lung EUD difference between the RP 2+ and non-RP 2+ groups. A strong correlation coefficient of 0.929 (P< 0.01) was observed between lung EUD (α = 0.3) and physical dose metrics. When examining predictive capabilities, lung EUD-based NTCP for the affected lung (AUC: 0.862) and whole lung (AUC: 0.815) surpassed LKB-based NTCP for the respective lungs. The decision tree (DT) model using lung EUD-based predictors emerged as the superior model, achieving an AUC of 0.98 in both training and validation datasets. Discussions: The likelihood of developing RP 2+ has shown a significant correlation with the advancements in RT technology. From traditional 3-D conformal RT, lung cancer treatment methodologies have transitioned to sophisticated techniques like static IMRT. Accurately deriving such a dose–effect relationship through NTCP modeling of RP incidence is statistically challenging due to the increased number of degrees-of-freedom. To the best of our knowledge, many studies have not clarified the rationale behind setting the α-value to 0.99 or 1, despite the closely aligned calculated lung EUD and lung mean dose MLD. Perfect independence among variables is rarely achievable in real-world scenarios. Four prominent machine learning algorithms were used to devise our prediction models. The inclusion of lung EUD-based factors substantially enhanced their predictive performance for RP 2+. Our results advocate for the decision tree model with lung EUD-based predictors as the optimal prediction tool for VMAT-treated lung cancer patients. Which could replace conventional dosimetric parameters, potentially simplifying complex neural network structures in prediction models.

From plan to delivery: Machine learning based positional accuracy prediction of multi‐leaf collimator and estimation of delivery effect in volumetric modulated arc therapy

Machine learning models to predict the delivered positions of Elekta multileaf collimator leaves for volumetric modulated arc therapy

Machine Learning for Patient-Specific Quality Assurance of VMAT: Prediction and Classification Accuracy.

[Impact of Multi-Leaf Collimator Positioning Accuracy on Quality Control of Volumetric Modulation Arc Therapy Plan for Cervical Cancer Treated with Elekta Linear Accelerator].

Improvement of deep learning prediction model in patient‐specific QA for VMAT with MLC leaf position map and patient's dose distribution

Analysis of multi-leaf collimator leaf position deviation in volumetric modulated arc therapy

Verification of the machine delivery parameters of a treatment plan via deep learning

Deep learning for patient-specific quality assurance of volumetric modulated arc therapy: Prediction accuracy and cost-sensitive classification performance

Implementation of volumetric-modulated arc therapy for locally advanced breast cancer patients: Dosimetric comparison with deliverability consideration of planning techniques and predictions of patient-specific QA results via supervised machine learning

Quantification of Treatment Plan Deliverability in Breast Volumetric-modulated Arc Therapy With Agility Multi-leaf Collimator

Implementation of phantom-less IMRT delivery verification using Varian DynaLog files and R/V output

Comparison of the Effects of Two Types of Multileaf Collimators on Tumor Control Probability in Radiotherapy for Breast Cancer after Conservative Surgery Based on the EUD Model ⁎

SU-HH-AUD C-03: Machine Learning Tools for Predicting Clinical Complications in a Multi-Plan IMRT Framework

Image-based Features in Machine Learning to Identify Delivery Errors and Predict Error Magnitude for Patient-Specific IMRT Quality Assurance

Multi-task autoencoder based classification-regression model for patient-specific VMAT QA.

Predicting radiation pneumonitis in lung cancer: a EUD-based machine learning approach for volumetric modulated arc therapy patients

Mitigating the uncertainty in small field dosimetry by leveraging machine learning strategies

The dosimetric impacts of accelerator operation error on the volumetric modulated arc therapy for cervical cancer

Machine Log File and Calibration Errors-based Patient-specific Quality Assurance (QA) for Volumetric Modulated Arc Therapy (VMAT).

Comparison of Dosimetric Effects of MLC Positional Errors on VMAT and IMRT Plans for SBRT Radiotherapy in Non-Small Cell Lung Cancer

A Comparative Study of Deep Learning Dose Prediction Models for Cervical Cancer Volumetric Modulated Arc Therapy